醫療科技
NEW

台微醫完成2.7億私募！ 亞美登健康科技創投、鐿鈦挹注 拓歐美市場
新聞集錦
NEW

11/20《生技股動態》

新聞集錦
NEW

Incyte 7.5億美元押注Escient 兩新藥臨床開發不利；64.7%患者皮膚改善！嬌生口服乾癬新藥挑戰BMS Sotyktu

新聞集錦
新聞集錦

01/02《生醫焦點雷達》

2024-01-02/新聞中心
健保將改支付標準最快明年上路聯合報2024/1/1醫院評鑑結果王必勝：延至1月中公布聯合報2024/12/31醫美新商機…外泌體管制鬆綁訊聯、永立榮等受惠經濟日報2024/1/2生技製藥佈局進入成長期興櫃股吸金轉上市櫃鉅亨網2024/12/31日本研究揭示可逆性嬰兒肝衰竭發病機制新華社2024/12/30NTTDOCOMO開發味覺重現技術，分享味覺體驗科技新報2024/12/31威力...
GBI International
GBIHighlights FDAApproval DrugDevelopment

Sunny Pharmtech hits another FDA milestone! AMA-S has received FDA approval.

2023-12-31/GlobalBio & Investment
SunnyPharmtechhitsanotherFDAmilestone! CongratulationstoSunnyPharmtechInc(6676.TWO)ontheirnewsuccess!TheirCPA-IsmoothlyshippedtotheU.S.earlierthismonth,andnowtheAMA-S(AminocaproicAcidSolution)hasrecei...
GBI International
GBIHighlights

Hualien Tzu Chi Hospital administers Taiwan's first CAR-T cell therapy

2023-12-31/GlobalBio & Investment
HualienTzuChiHospitalmarksamilestoneonJan2ndbyadministeringTaiwan'sfirstCAR-TcelltherapyunderNationalHealthInsurance.Thisinnovativetreatment,conditionallyincludedinthetemporarypaymentlistsinceNove...
GBI International
GBIHighlights

Reflecting on 2023: a year filled with hope, challenges, and resilience in biomedicine

2023-12-31/GlobalBio & Investment
Reflectingon2023:ayearfilledwithhope,challenges,andresiliencein #biomedicine.Let’srevisitthehighlightsandembrace2024withenthusiasm! Wewanttothankyouforyourunwaveringsupportinexploringthewonderso...
GBI International
GBIHighlights

Join BE Health's Proof of Clinical Evidence Acceleration Program before the deadline!

2023-12-31/GlobalBio & Investment
Callallinnovators!JoinBEHealth's #PoC (ProofofClinicalEvidence)AccelerationProgrambeforethedeadline!Tailoredforprecisionmedicine,medicaldevices,anddigitalhealth,itoffers5-6monthsofsupport,a$500,00...
GBI International
GBI Highlights

AdvMeds now serves 12 countries with 3 million+ users worldwide!

2023-12-31/GlobalBio & Investment
Breakingtheboundaries!AdvMeds,ahealthcareinformationsystemcompanyfromTaiwan,nowserves12countrieswith3million+usersworldwide!DuringCOVID-19,AdvMedsstoodoutbyprovidingdigitalhealthcaresolutionsandpartne...
GBI International
GBIHighlights

Prof. Cheng-Hsun Chiu emphasizes the critical need for a "Virology to Clinical Blueprint"

2023-12-31/GlobalBio & Investment
Preparetoprevent#2:WeareexcitedtoshareinsightsfromProf.Cheng-HsunChiu,DeputySuperintendentat 長庚醫院.HeisalsotheleaderofAdvageneBiopharma'sCOVID-19drugAD17002-SC'sphase2atrial.Prof.Chiuemphasizes...
GBI International
GBI Highlights

Meet the startup CEO, Bon Lee, CEO of MedFluid Co., Ltd.

2023-12-31/GlobalBio & Investment
MeetthestartupCEO.BonLee,CEOof MedFluidCo.,Ltd. shiftedfromengineertoentrepreneur,valuingproblem-solving.Butleadingacompanydemandsmore!Prioritizingrevenuemeansfocusingonurgentuserneedsandcreatingswift...
GBI International
GBIHighlights

Dr. Tse Wen Chang, Taiwan's antibody pioneer, invented Xolair which was the first anti-IgE antibody

2023-12-31/GlobalBio & Investment
Excitingnewsintheantibodyworld!Dr.TseWenChang,Taiwan'santibodypioneer,inventedXolair(#omalizumab)whichwasthefirstanti-IgEantibody.FDAisexpectedtoreviewitssBLAsubmittedbyRocheforfoodallergybyQ12024...
GBI International
GBIHighlights

Learn from Dr. Andrea Carfi, Moderna’s Chief Scientific Officer, about their mRNA library...

2023-12-31/GlobalBio & Investment
Preparetoprevent#1Prepareforthenextpandemic?Moderna’svaccinestrategyisunderway!Howdotheyusepastexperiencestoswiftlydevelopvaccinesagainstunknownthreats?LearnfromDr. AndreaCarfi, Moderna’sC...
GBI International
GBIHighlights

Jellox partnered with China Medical University Hospital to bring digital pathology tech to Malaysia

2023-12-31/GlobalBio & Investment
Kudosto JelloXBiotechInc. foradvancinghealthcaredigitizationinMalaysia!!JelloxpartneredwithChinaMedicalUniversityHospital(#CMUH)tobringdigitalpathologytechtoMalaysiaunderTaiwan's"OneCountry,O...
GBI International
GBIHighlights

BRIM Biotechnology, Inc. ’s dry eye drug missed the primary goal in its late-stage trial

2023-12-31/GlobalBio & Investment
Everysetbackisasteppingstone!Thejourneyofdrugdevelopmentisascientificexploration.Eachhurdleisn’ttheendgame. BRIMBiotechnology,Inc. ’sdryeyedrugmissedtheprimarygoalinitslate-stagetrial.What...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務